Citations: Peroxisome Proliferator Activated Receptor Agonists: Emerging Therapy for Cardiovascular Complications

Balakumar, P., A.P. Singh, S.S. Ganti and M. Singh, 2007. Hyperhomocysteinemia and cardiovascular disorders: Is there a correlation? Trends Med. Res., 2: 160-166.
CrossRef | Direct Link |

Balakumar, P., M. Rose and M. Singh, 2007. Effect of fenofibrate in pressure overload-induced experimental cardiac hypertrophy. Int. J. Biol. Chem., 1: 104-110.
CrossRef | Direct Link |

Citations in impact factor journal as recorded by

Suppression of isoproterenol-induced cardiotoxicity in rats by raspberry ketone via activation of peroxisome proliferator activated receptor-α

European Journal of Pharmacology

Potential target sites to modulate vascular endothelial dysfunction: Current perspectives and future directions

Toxicology Vol. 245, Issue 1-2, 49, 2008

Resident Cardiac Mast Cells: Are They the Major Culprit in the Pathogenesis of Cardiac Hypertrophy?

Basic & Clinical Pharmacology & Toxicology Vol. 0, Issue 0, 071031053307001, 2007

Citation to this article as recorded by

Effect of Fenofibrate in Pressure Overload-induced Experimental Cardiac Hypertrophy

International Journal of Biological Chemistry Vol. 1, Issue 2, 104, 2007

Hyperhomocysteinemia and Cardiovascular Disorders: Is There a Correlation?

Trends in Medical Research Vol. 2, Issue 4, 160, 2007

Citations for "Peroxisome Proliferator Activated Receptor Agonists: Emerging Therapy for Cardiovascular Complications"

Citation to this article as recorded by

Citations in impact factor journal as recorded by

Citation to this article as recorded by